The GREACE study emphasizes the urgent need for a wider use of lipid-lowering drugs in high-risk patients. Evaluation (GREACE) Study consisted of patients with coronary heart disease (CHD) followed up for three years1. The patients were randomised to either. Our post-hoc analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study was done to address this issue. Because of the.
|Published (Last):||19 December 2018|
|PDF File Size:||4.23 Mb|
|ePub File Size:||16.14 Mb|
|Price:||Free* [*Free Regsitration Required]|
Long-term treatment of CHD patients with atorvastatin to achieve NCEP lipid targets significantly reduces total and coronary mortality, coronary morbidity and stroke, in comparison to patients receiving ‘usual’ medical care.
Disclosures Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality.
You may not use the website for any unlawful purpose, including without limitation, to upload, post, download or otherwise use any Material that you do not have the copyright owners permission to so upload, post, download or otherwise use, or that would result in you being in breach of these terms and conditions. Treatment with atorvastatin is well tolerated and cost-effective.
The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. – Semantic Scholar
Withdrawal of patients because of side-effects from the atorvastatin group was low 0. Institutional access Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution. I would like sstudy receive updates when further comments, recommendations, or dissenting opinions are publishing on this article.
Examples of ‘Non-Financial Competing Interests’ Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. treace
I am a Faculty Member who recommended this article. You hereby agree to indemnify and keep indemnified F, its affiliates, greeace and agents from and against any and all losses including without limitation stuxy, indirect and consequential losscosts, claims, damages or expenses of whatever nature and howsoever caused arising directly or indirectly from any breach of these Terms and Conditions or arising from the Material posted on this website or content contained in any email sent using the facilities provided by the website by you including without limitation as a result of any infringement of any intellectual property or other proprietary rights, libel, defamation, obscenity or the Material being otherwise unlawful.
You are a close professional associate of any of the authors e. F reserves the right to monitor all Material and to remove any Material which it considers in its absolute discretion to grecae unlawful, inappropriate, offensive or otherwise in breach of these Terms and Conditions. A summary of the content will be automatically included.
Please disclose any competing interests that might be construed to influence your judgment of the validity or importance of the article, or any recommendation or review. These terms shall be governed by and construed in accordance with English Law. All patients were stydy up for a wtudy period of 3 years. Certain parts of this website offer the opportunity for users to post opinions, information and greafe including without limitation academic papers and data ‘Material’ in areas of the website.
Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution. Comment in Curr Med Res Opin.
F does not store recipient email addresses. You are entitled to post or upload the Material on the website and have all necessary licenses and consents to do so; the Material does not infringe any intellectual property right, including without limitation copyright, patent or trademark, or other proprietary right of any third party; the Material does not contain any defamatory, libellous, offensive, indecent or otherwise unlawful material or material which is an invasion of privacy; the Material does not contain stufy contaminating or destructive features or devices such as viruses, time bombs or coding designed to interrupt, destroy or limit the functionality of this website or any of this website’s user’s computer equipment or software; the Material will not be used to solicit or promote business or custom or present commercial activities or unlawful activity; and the Material is in compliance with all applicable laws.
In detail, atorvastatin reduced, in comparison to ‘usual’ care, total mortality RR 0. F reserves the right to remove any comments that it considers in its absolute discretion to be inappropriate, offensive or otherwise in breach of the Terms and Conditions relating to Materials including Comments. Statin treatment is safe and can improve liver tests and reduce cardiovascular morbidity grezce patients with mild-to-moderately abnormal liver tests that are potentially attributable to non-alcoholic fatty liver disease.
F does not claim any ownership in the Material that you or any other user posts. All subgroups of patients women, those with diabetes mellitus, arterial hypertension, age 60 to 75 years, congestive heart failure, recent unstable angina or prior revascularisation benefited from treatment with atorvastatin. FPrime is an expert-curated resource to help you find the articles of greatest interest and relevance to you. Accordingly you may only post Material that you have the right to do so.
Consider the following examples, but note that this is dtudy an exhaustive list:.
You are an Editor for the journal in which the article is published. To assess the effect of atorvastatin on morbidity and mortality total and coronary of patients with established coronary heart disease CHDconsecutive patients were randomised either to atorvastatin or to ‘usual’ medical care.
I am an author of this article. Recommend to your librarian.
Secondary endpoints were the safety and efficacy of the hypolipidaemic drugs as well as the cost-effectiveness of atorvastatin. You work at the same institute as any of the authors.